Enzychem Lifesciences Announces FDA Acceptance of Phase 2 Study of EC-18 in Preventing Acute Respiratory > 언론보도

본문 바로가기

최신소식

Enzychem Lifesciences Announces FDA Acceptance of Phase 2 Study of EC-…

페이지 정보

본문

06ddfbefc8eb61b5384eab726ce9b2d9_1598918712_369.jpg
06ddfbefc8eb61b5384eab726ce9b2d9_1598918715_4449.jpg
 

Top